Incidence of Neoplasms in Patients Who Develop Sustained Leukopenia During or After Treatment With 6-Mercaptopurine for Inflammatory Bowel Disease William Disanti, Ramona O. Rajapakse, Burton I. Korelitz, Georgia Panagopoulos, Jason Bratcher Clinical Gastroenterology and Hepatology Volume 4, Issue 8, Pages 1025-1029 (August 2006) DOI: 10.1016/j.cgh.2006.03.018 Copyright © 2006 American Gastroenterological Association Terms and Conditions
Figure 1 Rate of neoplasms after 6-MP for IBD in sustained leukopenic vs control groups. Clinical Gastroenterology and Hepatology 2006 4, 1025-1029DOI: (10.1016/j.cgh.2006.03.018) Copyright © 2006 American Gastroenterological Association Terms and Conditions